Hadebe, B.; Harry, L.; Gabela, L.; Masikane, S.; Patel, M.; Zwane, S.; Pillay, V.; Bipath, P.; Cebekhulu, N.; Nyakale, N.;
et al. Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry. Diagnostics 2024, 14, 1375.
https://doi.org/10.3390/diagnostics14131375
AMA Style
Hadebe B, Harry L, Gabela L, Masikane S, Patel M, Zwane S, Pillay V, Bipath P, Cebekhulu N, Nyakale N,
et al. Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry. Diagnostics. 2024; 14(13):1375.
https://doi.org/10.3390/diagnostics14131375
Chicago/Turabian Style
Hadebe, Bawinile, Lerwine Harry, Lerato Gabela, Siphelele Masikane, Maryam Patel, Sizwe Zwane, Venesen Pillay, Presha Bipath, Nonhlanhla Cebekhulu, Nozipho Nyakale,
and et al. 2024. "Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry" Diagnostics 14, no. 13: 1375.
https://doi.org/10.3390/diagnostics14131375
APA Style
Hadebe, B., Harry, L., Gabela, L., Masikane, S., Patel, M., Zwane, S., Pillay, V., Bipath, P., Cebekhulu, N., Nyakale, N., Ramdass, P., Msimang, M., Aldous, C., Sathekge, M., & Vorster, M.
(2024). Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry. Diagnostics, 14(13), 1375.
https://doi.org/10.3390/diagnostics14131375
